CD274 and lung carcinoma: In addition, approved immunotherapy for lung cancer is aimed at the reversal of immune checkpoints, programmed death protein-1 (PD-1) and programmed death ligand-1 (PD-L1), and it has a good therapeutic effect in specific lung cancer patients [6].